This is new and dif from the head and neck nccn trial that oncologie mentioned on website which is another merck/keytruda trial. So my guess is merck is an investor in oncologie given oncologie owns the IP now. So I would expect a milestone payment as well as follow up to the initial $8 mil. And possibly bavi manuf (unless they had enough to complete trial).
SK ... you were so close but the shareholders finally had the horsepower to kick you out. All you had to do was a deal.
News 
Market Data 
Discover 
